Biotechnology - Crown Point, Indiana, United States
Neurodon Scientists have discovered small molecules that represent a potential cure for Alzheimer's Disease (AD) via modulation of a novel target. Our compounds are effective in multiple animal models of AD addressing both synaptic function and memory. All of the current clinical trials for Alzheimer's Disease (AD) that focus on clearing amyloid plaques have failed. Neurodon compounds modulate a new target UPSTREAM of A-beta and are able to heal neuronal function which is linked to memory and cognition.
Outlook
Mobile Friendly
GoDaddy Hosting